FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/29/2024
Back to search
Official data from USPTO
RADELUMIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/29/2024
Trademark type
Combined
Nice classes
5
Filing date
05/19/2022
Registration date
12/12/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/12/2023
Last transaction
12/12/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
27
Owner location
DE
Examiner
MAHMOUDI, MARIAM
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "radelumin" to the right of a design consisting of a shaded circle containing an off-center circle and around which are four partial circles.
Holders and representatives
Holders
ABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbH
Representatives
Philip C. Schroeder Buchalter
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and beverages adapted for medical or veterinary purposes; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the diagnosis of cancer; biological preparations for medical or pharmaceutical purposes for the treatment of cancer; preparations for use in medical diagnostic processesdiagnostic preparations for medical purposes; preparations for use in medical diagnostic processesdiagnostic preparations for medical purposes relating to the diagnosis of diseases of the prostate; preparations for use in medical diagnostic processesdiagnostic preparations for medical purposes relating to the diagnosis of cancer
Publications
History of USPTO decisions and trademark events.
26 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/14/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
03/14/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/12/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/12/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/26/2023
PUBO
PUBLISHED FOR OPPOSITION
09/26/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/25/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/06/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/22/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/21/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/21/2023
RFNT
REFUSAL PROCESSED BY IB
04/13/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/20/2023
RFRR
REFUSAL PROCESSED BY MPU
03/20/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/25/2023
CNRT
NON-FINAL ACTION WRITTEN
01/24/2023
DOCK
ASSIGNED TO EXAMINER
01/18/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/30/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/26/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/22/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/15/2022
Continuous trademark protection
Get notified about every new filing that threatens RADELUMIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.